Does the media favor IRTC or BAX?

In the previous week, Baxter International had 42 more articles in the media than iRhythm Technologies. MarketBeat recorded 51 mentions for Baxter International and 9 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.09 beat Baxter International's score of 0.76 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Baxter International 18 Very Positive mention(s) 8 Positive mention(s) 17 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Which has better valuation and earnings, IRTC or SNN?

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies. Company Gross Revenue Price/Sales Ratio Net Income Earnings Per Share Price/Earnings Ratio iRhythm Technologies $747.14M 5.15 -$44.55M -$0.86 N/A Smith & Nephew SNATS $6.16B 2.16 $625M N/A N/A

Does the media prefer IRTC or SNN?

In the previous week, iRhythm Technologies had 4 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 9 mentions for iRhythm Technologies and 5 mentions for Smith & Nephew SNATS. iRhythm Technologies' average media sentiment score of 1.09 beat Smith & Nephew SNATS's score of 0.68 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Smith & Nephew SNATS 2 Very Positive mention(s) 0 Positive mention(s) 3 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor PEN or IRTC?

In the previous week, Penumbra had 4 more articles in the media than iRhythm Technologies. MarketBeat recorded 13 mentions for Penumbra and 9 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.09 beat Penumbra's score of 0.92 indicating that iRhythm Technologies is being referred to more favorably in the news media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Penumbra 7 Very Positive mention(s) 1 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

Does the media favor IRTC or PODD?

In the previous week, Insulet had 38 more articles in the media than iRhythm Technologies. MarketBeat recorded 47 mentions for Insulet and 9 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.09 beat Insulet's score of 0.46 indicating that iRhythm Technologies is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment iRhythm Technologies 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive Insulet 15 Very Positive mention(s) 2 Positive mention(s) 29 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Neutral

Does the media favor GMED or IRTC?

In the previous week, Globus Medical had 13 more articles in the media than iRhythm Technologies. MarketBeat recorded 22 mentions for Globus Medical and 9 mentions for iRhythm Technologies. Globus Medical's average media sentiment score of 1.24 beat iRhythm Technologies' score of 1.09 indicating that Globus Medical is being referred to more favorably in the media. Company Very Positive Positive Neutral Negative Very Negative Overall Sentiment Globus Medical 16 Very Positive mention(s) 0 Positive mention(s) 5 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive iRhythm Technologies 5 Very Positive mention(s) 0 Positive mention(s) 4 Neutral mention(s) 0 Negative mention(s) 0 Very Negative mention(s) Positive

iRhythm Technologies (IRTC) Competitors

$117.17 0.00 (0.00%)

Closing price 07/31/2026 04:00 PM Eastern

Extended Trading

$117.10 -0.07 (-0.06%)

As of 07/31/2026 07:34 PM Eastern

Compare

IRTC vs. BAX, SNN, PEN, PODD, and GMED

Should you buy iRhythm Technologies stock or one of its competitors? MarketBeat compares iRhythm Technologies with other companies and stocks that may be similar based on industry, sector, market capitalization, business model, investor interest, or shared news coverage. Companies and stocks commonly compared with iRhythm Technologies include Baxter International (BAX), Smith & Nephew SNATS (SNN), Penumbra (PEN), Insulet (PODD), and Globus Medical (GMED). These companies are all part of the "healthcare equipment" industry.

How does iRhythm Technologies compare to Baxter International?

iRhythm Technologies (NASDAQ:IRTC) and Baxter International (NYSE:BAX) are both healthcare companies, but which is the superior investment? We will contrast the two businesses based on the strength of their dividends, risk, analyst recommendations, earnings, profitability, media sentiment, institutional ownership and valuation.

iRhythm Technologies has higher earnings, but lower revenue than Baxter International. iRhythm Technologies is trading at a lower price-to-earnings ratio than Baxter International, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.15	-$44.55M	-$0.86	N/A
Baxter International	$11.24B	1.20	-$957M	-$2.07	N/A

iRhythm Technologies presently has a consensus price target of $184.71, indicating a potential upside of 57.65%. Baxter International has a consensus price target of $22.45, indicating a potential downside of 14.30%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, research analysts plainly believe iRhythm Technologies is more favorable than Baxter International.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Baxter International	3 Sell rating(s)	8 Hold rating(s)	2 Buy rating(s)	0 Strong Buy rating(s)	1.92

In the previous week, Baxter International had 42 more articles in the media than iRhythm Technologies. MarketBeat recorded 51 mentions for Baxter International and 9 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.09 beat Baxter International's score of 0.76 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Baxter International	18 Very Positive mention(s)	8 Positive mention(s)	17 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market. Comparatively, Baxter International has a beta of 0.59, suggesting that its stock price is 41% less volatile than the broader market.

90.2% of Baxter International shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by company insiders. Comparatively, 0.2% of Baxter International shares are owned by company insiders. Strong institutional ownership is an indication that endowments, large money managers and hedge funds believe a company will outperform the market over the long term.

iRhythm Technologies has a net margin of -3.53% compared to Baxter International's net margin of -9.27%. Baxter International's return on equity of 16.57% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Baxter International	-9.27%	16.57%	5.24%

Summary

iRhythm Technologies beats Baxter International on 11 of the 17 factors compared between the two stocks.

How does iRhythm Technologies compare to Smith & Nephew SNATS?

iRhythm Technologies (NASDAQ:IRTC) and Smith & Nephew SNATS (NYSE:SNN) are both healthcare companies, but which is the superior stock? We will compare the two companies based on the strength of their analyst recommendations, profitability, risk, valuation, institutional ownership, dividends, media sentiment and earnings.

25.6% of Smith & Nephew SNATS shares are owned by institutional investors. 1.0% of iRhythm Technologies shares are owned by insiders. Comparatively, 1.0% of Smith & Nephew SNATS shares are owned by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company will outperform the market over the long term.

Smith & Nephew SNATS has a net margin of 0.00% compared to iRhythm Technologies' net margin of -3.53%. Smith & Nephew SNATS's return on equity of 0.00% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Smith & Nephew SNATS	N/A	N/A	N/A

Smith & Nephew SNATS has higher revenue and earnings than iRhythm Technologies.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.15	-$44.55M	-$0.86	N/A
Smith & Nephew SNATS	$6.16B	2.16	$625M	N/A	N/A

iRhythm Technologies has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market. Comparatively, Smith & Nephew SNATS has a beta of 0.56, suggesting that its stock price is 44% less volatile than the broader market.

In the previous week, iRhythm Technologies had 4 more articles in the media than Smith & Nephew SNATS. MarketBeat recorded 9 mentions for iRhythm Technologies and 5 mentions for Smith & Nephew SNATS. iRhythm Technologies' average media sentiment score of 1.09 beat Smith & Nephew SNATS's score of 0.68 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Smith & Nephew SNATS	2 Very Positive mention(s)	0 Positive mention(s)	3 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

iRhythm Technologies presently has a consensus price target of $184.71, suggesting a potential upside of 57.65%. Smith & Nephew SNATS has a consensus price target of $30.93, suggesting a potential downside of 1.92%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Smith & Nephew SNATS.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Smith & Nephew SNATS	0 Sell rating(s)	5 Hold rating(s)	1 Buy rating(s)	0 Strong Buy rating(s)	2.17

Summary

iRhythm Technologies beats Smith & Nephew SNATS on 8 of the 15 factors compared between the two stocks.

How does iRhythm Technologies compare to Penumbra?

Penumbra (NYSE:PEN) and iRhythm Technologies (NASDAQ:IRTC) are both healthcare companies, but which is the better stock? We will compare the two businesses based on the strength of their earnings, valuation, profitability, analyst recommendations, institutional ownership, risk, media sentiment and dividends.

Penumbra currently has a consensus price target of $367.07, indicating a potential upside of 14.21%. iRhythm Technologies has a consensus price target of $184.71, indicating a potential upside of 57.65%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Penumbra.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Penumbra	1 Sell rating(s)	13 Hold rating(s)	3 Buy rating(s)	0 Strong Buy rating(s)	2.12
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

Penumbra has a beta of 0.7, suggesting that its stock price is 30% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market.

Penumbra has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Penumbra, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Penumbra	$1.40B	9.02	$177.69M	$4.07	78.97
iRhythm Technologies	$747.14M	5.15	-$44.55M	-$0.86	N/A

Penumbra has a net margin of 10.67% compared to iRhythm Technologies' net margin of -3.53%. Penumbra's return on equity of 10.50% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Penumbra	10.67%	10.50%	8.17%
iRhythm Technologies	-3.53%	-10.26%	-1.39%

In the previous week, Penumbra had 4 more articles in the media than iRhythm Technologies. MarketBeat recorded 13 mentions for Penumbra and 9 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.09 beat Penumbra's score of 0.92 indicating that iRhythm Technologies is being referred to more favorably in the news media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Penumbra	7 Very Positive mention(s)	1 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
iRhythm Technologies	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

88.9% of Penumbra shares are held by institutional investors. 2.9% of Penumbra shares are held by insiders. Comparatively, 1.0% of iRhythm Technologies shares are held by insiders. Strong institutional ownership is an indication that large money managers, hedge funds and endowments believe a company is poised for long-term growth.

Summary

Penumbra beats iRhythm Technologies on 11 of the 17 factors compared between the two stocks.

How does iRhythm Technologies compare to Insulet?

iRhythm Technologies (NASDAQ:IRTC) and Insulet (NASDAQ:PODD) are both healthcare companies, but which is the superior investment? We will compare the two companies based on the strength of their risk, valuation, earnings, profitability, analyst recommendations, dividends, institutional ownership and media sentiment.

iRhythm Technologies has a beta of 1.3, meaning that its share price is 30% more volatile than the broader market. Comparatively, Insulet has a beta of 1.11, meaning that its share price is 11% more volatile than the broader market.

Insulet has a net margin of 10.44% compared to iRhythm Technologies' net margin of -3.53%. Insulet's return on equity of 26.87% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
iRhythm Technologies	-3.53%	-10.26%	-1.39%
Insulet	10.44%	26.87%	12.01%

In the previous week, Insulet had 38 more articles in the media than iRhythm Technologies. MarketBeat recorded 47 mentions for Insulet and 9 mentions for iRhythm Technologies. iRhythm Technologies' average media sentiment score of 1.09 beat Insulet's score of 0.46 indicating that iRhythm Technologies is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
iRhythm Technologies	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
Insulet	15 Very Positive mention(s)	2 Positive mention(s)	29 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Neutral

iRhythm Technologies presently has a consensus price target of $184.71, indicating a potential upside of 57.65%. Insulet has a consensus price target of $233.38, indicating a potential upside of 41.14%. Given iRhythm Technologies' stronger consensus rating and higher possible upside, equities analysts plainly believe iRhythm Technologies is more favorable than Insulet.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94
Insulet	2 Sell rating(s)	5 Hold rating(s)	21 Buy rating(s)	0 Strong Buy rating(s)	2.68

Insulet has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Insulet, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
iRhythm Technologies	$747.14M	5.15	-$44.55M	-$0.86	N/A
Insulet	$2.90B	3.95	$247.10M	$4.30	38.45

Summary

Insulet beats iRhythm Technologies on 9 of the 15 factors compared between the two stocks.

How does iRhythm Technologies compare to Globus Medical?

Globus Medical (NYSE:GMED) and iRhythm Technologies (NASDAQ:IRTC) are both healthcare companies, but which is the better investment? We will contrast the two businesses based on the strength of their risk, profitability, valuation, analyst recommendations, dividends, media sentiment, earnings and institutional ownership.

Globus Medical has a net margin of 18.92% compared to iRhythm Technologies' net margin of -3.53%. Globus Medical's return on equity of 13.46% beat iRhythm Technologies' return on equity.

Company	Net Margins	Return on Equity	Return on Assets
Globus Medical	18.92%	13.46%	11.65%
iRhythm Technologies	-3.53%	-10.26%	-1.39%

In the previous week, Globus Medical had 13 more articles in the media than iRhythm Technologies. MarketBeat recorded 22 mentions for Globus Medical and 9 mentions for iRhythm Technologies. Globus Medical's average media sentiment score of 1.24 beat iRhythm Technologies' score of 1.09 indicating that Globus Medical is being referred to more favorably in the media.

Company	Very Positive	Positive	Neutral	Negative	Very Negative	Overall Sentiment
Globus Medical	16 Very Positive mention(s)	0 Positive mention(s)	5 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive
iRhythm Technologies	5 Very Positive mention(s)	0 Positive mention(s)	4 Neutral mention(s)	0 Negative mention(s)	0 Very Negative mention(s)	Positive

Globus Medical has higher revenue and earnings than iRhythm Technologies. iRhythm Technologies is trading at a lower price-to-earnings ratio than Globus Medical, indicating that it is currently the more affordable of the two stocks.

Company	Gross Revenue	Price/Sales Ratio	Net Income	Earnings Per Share	Price/Earnings Ratio
Globus Medical	$2.94B	3.65	$537.87M	$4.30	18.37
iRhythm Technologies	$747.14M	5.15	-$44.55M	-$0.86	N/A

Globus Medical presently has a consensus target price of $102.08, indicating a potential upside of 29.23%. iRhythm Technologies has a consensus target price of $184.71, indicating a potential upside of 57.65%. Given iRhythm Technologies' stronger consensus rating and higher probable upside, analysts plainly believe iRhythm Technologies is more favorable than Globus Medical.

Company	Sell Ratings	Hold Ratings	Buy Ratings	Strong Buy Ratings	Rating Score
Globus Medical	0 Sell rating(s)	6 Hold rating(s)	9 Buy rating(s)	2 Strong Buy rating(s)	2.76
iRhythm Technologies	1 Sell rating(s)	1 Hold rating(s)	12 Buy rating(s)	2 Strong Buy rating(s)	2.94

95.2% of Globus Medical shares are owned by institutional investors. 18.4% of Globus Medical shares are owned by company insiders. Comparatively, 1.0% of iRhythm Technologies shares are owned by company insiders. Strong institutional ownership is an indication that large money managers, endowments and hedge funds believe a stock is poised for long-term growth.

Globus Medical has a beta of 0.95, suggesting that its stock price is 5% less volatile than the broader market. Comparatively, iRhythm Technologies has a beta of 1.3, suggesting that its stock price is 30% more volatile than the broader market.

Summary

Globus Medical beats iRhythm Technologies on 11 of the 16 factors compared between the two stocks.

Get iRhythm Technologies News Delivered to You Automatically

Subscribe Now

SMS is currently available in Australia, Belgium, Canada, France, Germany, Ireland, Italy, New Zealand, the Netherlands, Singapore, South Africa, Spain, Switzerland, the United Kingdom, and the United States. By entering your phone number and clicking the sign-up button, you agree to receive periodic text messages from MarketBeat at the phone number you submitted, including texts that may be sent using an automatic telephone dialing system. Message and data rates may apply. Message frequency will vary. Messages will consist of stock alerts, news stories, and partner advertisements/offers. Consent is not a condition of the purchase of any goods or services. Text HELP for help/customer support. Unsubscribe at any time by replying "STOP" to any text message that you receive from MarketBeat or by visiting our mailing preferences page. Read our full terms of service and privacy policy.

New MarketBeat Followers Over Time

This chart shows the number of new MarketBeat users adding IRTC and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period.

Media Sentiment Over Time

This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.

IRTC vs. The Competition

Export

Metric	iRhythm Technologies	Healthcare Equipment & Supplies Industry	Healthcare Sector	NASDAQ Exchange
Market Cap	$3.85B	$5.58B	$6.86B	$12.42B
Dividend Yield	N/A	1.79%	2.59%	10.03%
P/E Ratio	-136.24	23.11	282.30	24.66
Price / Sales	5.15	56.88	564.98	76.51
Price / Cash	N/A	32.53	28.60	46.71
Price / Book	24.72	6.29	10.92	6.07
Net Income	-$44.55M	$151.15M	$3.49B	$347.99M
7 Day Performance	4.48%	0.96%	-0.64%	-0.44%
1 Month Performance	-7.36%	-3.50%	-5.24%	-4.81%
1 Year Performance	-28.97%	2.31%	61.98%	18.61%

iRhythm Technologies Competitors List

Export

Company	MarketRank	Share Price	Analysts' Price Target	1Y Price Performance	Market Cap	Revenue	P/E Ratio	Employee Count	Indicator(s)
IRTC iRhythm Technologies	4.2522 of 5 stars	$117.17 flat	$184.71 +57.6%	-29.0%	$3.85B	$747.14M	N/A	2,400	Upcoming Earnings
BAX Baxter International	1.3604 of 5 stars	$26.20 -2.1%	$22.45 -14.3%	+19.3%	$13.82B	$11.47B	N/A	37,500	Trending News Earnings Report Dividend Announcement Analyst Upgrade
SNN Smith & Nephew SNATS	1.9857 of 5 stars	$31.53 -2.5%	$30.93 -1.9%	+2.1%	$13.66B	$6.16B	N/A	16,988	News Coverage Upcoming Earnings Gap Down
PEN Penumbra	2.9928 of 5 stars	$321.40 +0.5%	$367.07 +14.2%	+32.5%	$12.58B	$1.50B	78.97	4,700	Earnings Report
PODD Insulet	4.722 of 5 stars	$165.35 -0.2%	$233.38 +41.1%	-42.0%	$11.48B	$2.71B	38.45	5,400	Trending News Upcoming Earnings Analyst Upgrade

Related Companies and Tools

Related Companies

Top 10 Stock Comparisons

This page (NASDAQ:IRTC) was last updated on 8/3/2026 by MarketBeat.com Staff.

From Our Partners

Unlock superior investment research and tools.

Get MarketBeat All Access

In-depth profiles and analysis for 20,000 public companies.
Real-time analyst ratings, insider transactions, earnings data, and more.
Our daily ratings and market update email newsletter.

Sign In
Create Account

Your Email Address:

Your Password:

Forgot your password?

Your Email Address:

Choose a Password:

By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

iRhythm Technologies (IRTC) Competitors

IRTC vs. BAX, SNN, PEN, PODD, and GMED

How does iRhythm Technologies compare to Baxter International?

Summary

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Summary

How does iRhythm Technologies compare to Penumbra?

Summary

How does iRhythm Technologies compare to Insulet?

Summary

How does iRhythm Technologies compare to Globus Medical?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRTC vs. The Competition

iRhythm Technologies Competitors List

Related Companies and Tools

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools

About MarketBeat

MarketBeat Products

Popular Tools

Financial Calendars

Terms & Info

iRhythm Technologies (IRTC) Competitors

IRTC vs. BAX, SNN, PEN, PODD, and GMED

How does iRhythm Technologies compare to Baxter International?

Which has stronger earnings & valuation, IRTC or BAX?

Do analysts rate IRTC or BAX?

Does the media favor IRTC or BAX?

Which has more risk and volatility, IRTC or BAX?

Do insiders & institutionals believe in IRTC or BAX?

Is IRTC or BAX more profitable?

Summary

How does iRhythm Technologies compare to Smith & Nephew SNATS?

Do institutionals & insiders hold more shares of IRTC or SNN?

Is IRTC or SNN more profitable?

Which has better valuation and earnings, IRTC or SNN?

Which has more volatility and risk, IRTC or SNN?

Does the media prefer IRTC or SNN?

Do analysts prefer IRTC or SNN?

Summary

How does iRhythm Technologies compare to Penumbra?

Do analysts prefer PEN or IRTC?

Which has more risk & volatility, PEN or IRTC?

Which has better valuation & earnings, PEN or IRTC?

Is PEN or IRTC more profitable?

Does the media favor PEN or IRTC?

Do institutionals and insiders have more ownership in PEN or IRTC?

Summary

How does iRhythm Technologies compare to Insulet?

Which has more volatility and risk, IRTC or PODD?

Is IRTC or PODD more profitable?

Does the media favor IRTC or PODD?

Do analysts recommend IRTC or PODD?

Which has higher earnings and valuation, IRTC or PODD?

Summary

How does iRhythm Technologies compare to Globus Medical?

Is GMED or IRTC more profitable?

Does the media favor GMED or IRTC?

Which has stronger valuation and earnings, GMED or IRTC?

Do analysts rate GMED or IRTC?

Do institutionals & insiders have more ownership in GMED or IRTC?

Which has more volatility & risk, GMED or IRTC?

Summary

New MarketBeat Followers Over Time

Media Sentiment Over Time

IRTC vs. The Competition

iRhythm Technologies Competitors List

Related Companies and Tools

MarketBeat All Access Features

Best-in-Class Portfolio Monitoring

Stock Ideas and Recommendations

Advanced Stock Screeners and Research Tools